Table 1: External dose based on FHMS basic survey, effective dose based on UNSCESAR report, number of primary examinees, confirmed or suspected cancer cases, thyroid cancer proportion per 100,000 (CP), odds ratio (OR) and 95% confidence interval (CI) in E-I, E-II, and E-I+II in OM-model according to Ohira’s map.
|
Area† |
External |
Effective |
E-I (FY2011–2013) |
E-II (FY2014–2015) |
E-I+II (FY2011–2015) |
||||||||
|
mSv |
mSv |
Examinees |
Cases |
CP |
OR |
Examinees |
Cases |
CP |
OR (CI) |
Cases |
CP‡ |
OR (CI) |
|
|
1 (C) |
0.91 |
4.60 |
59,621 |
20 |
33.5 |
0.92 |
51,160 |
19 |
37.1 |
2.28(0.9-5.7) |
39 |
70.7 |
1.34(0.8-2.3) |
|
2 (A+B) |
1.38 |
4.99 |
119,648 |
47 |
39.3 |
1.08 |
107,107 |
33 |
30.8 |
1.89(0.8-4.5) |
80 |
70.1 |
1.33(0.8-2.2) |
|
3 (D) |
0.52 |
2.73 |
82,625 |
34 |
41.1 |
1.13 |
75,421 |
13 |
17.2 |
1.06(0.4-2.8) |
47 |
58.4 |
1.11(0.7-1.9) |
|
4 (E) |
0.25 |
1.66 |
38,579 |
14 |
36.3 |
1(Ref.) |
36,823 |
6 |
16.3 |
1 (Ref.) |
20 |
52.6 |
1 (Ref.) |
|
Ave. / Sum |
0.77 |
3.48 |
300,473 |
115 |
38.3 |
270,511 |
71 |
26.2 |
186 |
64.5 |
|||
† Area name in the parentheses is the name in Refs. [5,7]. ‡ CP in I + II is the sum of those for I and II.
† Area name in the parentheses is the name in Refs. [5,7]. ‡ CP in I + II is the sum of those for I and II.